Calf Implant in India and UAE | Complete Patient Guide

• IDEAL CANDIDATES: Patients with congenitally underdeveloped calves (bilateral or unilateral) who have completed skeletal maturity (typically age 18+)

• Patients with asymmetric calf musculature resulting from prior orthopedic conditions such as club foot (talipes equinovarus), leg length discrepancy correction, or tibial osteotomies

• Individuals with neuromuscular atrophy secondary to resolved poliomyelitis, peroneal nerve palsy, or Charcot-Marie-Tooth disease (mild cases with stable neurological status)

• Bodybuilders and fitness athletes seeking enhanced lower-leg proportionality that cannot be achieved through hypertrophy training alone

• Transgender women (MTF) seeking feminization of lower-leg contours

• REQUIRED PREOPERATIVE DIAGNOSTICS: Complete blood count (CBC), coagulation profile (PT/aPTT/INR), serum metabolic panel, fasting blood glucose and HbA1c (diabetes screening), ECG and cardiac clearance for patients over 40 or with cardiac history, lower-leg duplex venous Doppler ultrasound (mandatory to rule out deep vein thrombosis and map small saphenous vein), high-resolution lower-leg ultrasound or MRI to assess fascial thickness and muscle belly dimensions, and standardized photographic documentation (anterior, posterior, lateral views)

• BMI assessment: Ideal BMI range is 18.5–29.9; patients with BMI above 30 require individualized assessment

• CONTRAINDICATIONS: Active deep vein thrombosis (DVT) or history of pulmonary embolism without adequate anticoagulation management, active lower-extremity peripheral arterial disease or compromised vascular supply, uncontrolled diabetes mellitus (HbA1c > 8.0%), active local or systemic infection, significant lower-leg lymphedema, unrealistic patient expectations or body dysmorphic disorder (BDD) — mandatory psychological screening is conducted at GAF Healthcare partner facilities, pregnancy or breastfeeding, and known hypersensitivity to silicone (rare but must be assessed)

SUBFASCIAL CALF IMPLANT PLACEMENT (GOLD STANDARD): The subfascial technique is the internationally preferred approach for calf augmentation. Under general anesthesia or spinal anesthesia with sedation, the surgeon makes a single 3–4 cm incision in the popliteal crease (the natural skin fold behind the knee), which provides excellent camouflage of the resulting scar. The deep fascia of the leg is incised longitudinally, and a precise subfascial pocket is dissected using a combination of blunt and electrocautery dissection — or increasingly with lighted retractors and endoscopic visualization — staying superficial to the gastrocnemius muscle belly. The solid silicone implant is inserted into the pocket, and its position is confirmed by intraoperative assessment of contour symmetry with the patient in both supine and prone positions. The fascia is closed with absorbable sutures (e.g., 0-Vicryl), followed by layered dermal closure with 3-0 Monocryl and skin-glue or steri-strip reinforcement. Both medial and lateral heads can be augmented through the same single posterior incision, using separate subfascial pockets.

INTRAMUSCULAR PLACEMENT (HISTORICAL / LIMITED USE): In this older technique, the implant is placed directly within the gastrocnemius muscle substance. While it can provide a more centrally projecting result for certain body types, it carries significantly higher rates of postoperative pain, implant migration, palpability, and potential for compartment pressure elevation. It has been largely superseded by the subfascial approach at GAF Healthcare-affiliated centers and is not routinely offered.

ENDOSCOPIC-ASSISTED CALF AUGMENTATION (ADVANCED): Available at select high-volume centers in India and the UAE, endoscopic-assisted pocket creation uses a 5 mm 30-degree endoscope introduced through the popliteal incision to visualize the fascial plane in real time. This technology reduces the risk of inadvertent injury to the sural nerve (which crosses the field laterally) and the small saphenous vein, allows more precise pocket dimensions, and is particularly beneficial in patients with thicker or less compliant fascial layers. The operative time is comparable to open dissection (60–90 minutes total for bilateral augmentation), with the added benefit of enhanced surgeon visualization.

IMPLANT TECHNOLOGIES: Modern calf implants are manufactured from high-cohesion solid silicone elastomer with a textured or smooth surface depending on surgeon preference and patient anatomy. Textured surfaces resist migration within the subfascial pocket; smooth surfaces allow a degree of positional adjustment and are associated with lower rates of capsular contracture in the subfascial plane. Anatomically pre-curved implants (matching the natural curve of the posterior calf) are strongly preferred over flat implants to achieve the most naturalistic contour. Volumetric selection is guided by preoperative 3D imaging where available. Implants do not require replacement on a fixed schedule and are designed to be lifetime devices, unlike breast implants, provided there is no capsular contracture, implant fracture, or positional displacement.

WEEK MINUS 2 TO 4 (PREOPERATIVE PREPARATION): GAF Healthcare coordinates the patient's complete preoperative workup remotely before travel. Digital consultation with the operating plastic surgeon is conducted via secure video call, during which anatomical photographs, measurements, and goals are reviewed. All required laboratory tests and imaging studies are organized at accredited diagnostic centers upon arrival in India or the UAE. Preoperative instructions include discontinuation of NSAIDs, aspirin, vitamin E, fish oil supplements, and any anticoagulants (under physician guidance) at least 10–14 days before surgery. Smoking cessation is required for a minimum of 4 weeks before and 4 weeks after surgery to optimize wound healing and reduce the risk of surgical site infection.

DAY 0 — PRE-ADMISSION AND SURGICAL DAY: The patient is admitted to the hospital on the morning of surgery following a minimum 6-hour fast (solids) and 2-hour fast (clear fluids) per international anesthesia protocols. Final implant size selection and pocket dimensions are confirmed with the surgeon using implant sizers and anthropometric measurements. Bilateral lower-leg DVT prophylaxis protocol is initiated with subcutaneous low-molecular-weight heparin (LMWH, e.g., enoxaparin) and fitted pneumatic compression stockings applied before induction of anesthesia. The procedure is performed under general anesthesia and takes approximately 60–120 minutes for bilateral augmentation. The patient is recovered in the post-anesthesia care unit (PACU) for 2–4 hours.

DAY 1–2 (IMMEDIATE POSTOPERATIVE PERIOD — INPATIENT): The patient remains in hospital for 1–2 nights for pain management, wound monitoring, and ambulation assessment. Intravenous analgesia transitions to oral analgesia (typically a combination of acetaminophen, celecoxib, and tramadol as required). Graduated compression stockings are worn continuously. The patient is encouraged to perform gentle ankle dorsiflexion/plantarflexion exercises to promote venous return and reduce DVT risk. The operating surgeon conducts a wound check before discharge. Discharge criteria include stable vital signs, controlled pain on oral medication, and the ability to ambulate independently with assistance.

WEEK 1–2 (EARLY RECOVERY — OUTPATIENT): The patient is advised to keep the legs elevated above the level of the heart as much as possible during the first 2 weeks to minimize swelling and ecchymosis. Walking with a flat-footed gait (avoiding heel-striking) is permitted and encouraged to prevent contracture, but prolonged standing, stair climbing, and any strenuous lower-leg activity are prohibited. The first postoperative outpatient review occurs at Day 7 for wound inspection and suture assessment (absorbable sutures do not require removal). Compression stockings are worn for a minimum of 4 weeks postoperatively. Swelling and bruising peak at approximately Days 3–5 and begin to subside over 2–3 weeks.

WEEK 3–4 (FIT-TO-FLY MILESTONE): By Week 3, the majority of patients have resolved acute swelling sufficiently to mobilize comfortably and tolerate a long-haul flight with appropriate DVT precautions. International flight is permitted after a minimum of 3–4 weeks post-surgery, provided the patient has clearance from the operating surgeon, wears graduated compression stockings during the flight, performs in-flight ankle exercises every 30–60 minutes, and maintains adequate hydration. The GAF Healthcare medical coordination team ensures the patient receives a formal fit-to-fly letter from the treating surgeon before departure.

WEEK 6–12 (PROGRESSIVE RECOVERY): Light cardiovascular activity (stationary cycling, swimming with wound healed) is typically resumed at 6 weeks. Return to resistance training involving the lower leg (calf raises, squats) is permitted at 8–12 weeks with surgeon clearance. Final aesthetic results, as swelling fully resolves, are typically visible by 3–6 months postoperatively. The posterior popliteal scar matures from pink to pale and becomes nearly imperceptible in most patients by 12–18 months.